Trial
NCT01546571
Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Polynoma LLC
Collaborators
—
Condition
Melanoma
Intervention
POL-103A
Why stopped
After interim analysis the study was halted to redesign a pivotal trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-24